Weight LossRESMRESG101NCT07608016
A Study to Evaluate a Supplement Combination in Supporting Weight Loss, Metabolic Health, and Quality of Life
A study testing Combination Prebiotic and Postbiotic in people with Weight Loss and Metabolic Health, run by Able Biolabs, LLC at 1 site in United States.
Trial summary
This consumer-use study evaluates the effects of a combined postbiotic and prebiotic supplement regimen on appetite control, cravings, metabolic health, energy, and quality of life in adults aged 18-65 years with a body mass index (BMI) between 25 and 30. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Weight Loss, Metabolic Health, Quality of Life
- What is being tested?
- Combination Prebiotic and Postbiotic
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 20 participants
- Where
- 1 siteUnited States
- Study dates
- 20 Oct 2025to 5 May 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Adults aged 18-65 years BMI between 25 and 30 Generally healthy Willing to comply with study procedures Access to smartphone or internet-enabled device for electronic questionnaires
- Exclusion Criteria Pregnant, planning pregnancy, or lactating History of bariatric surgery Prescription weight loss medication use within the past 90 days Current GLP-1 drug use History of substance abuse within the past 6 months Current use of supplements containing overlapping active ingredients Significant medical condition that may interfere with study participation or interpretation of results
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: A Consumer Study to Evaluate the Efficacy of a Postbiotic and Prebiotic Supplement Combination in Supporting Weight Loss, Metabolic Health, and Quality of Life
This consumer-use study evaluates the effects of a combined postbiotic and prebiotic supplement regimen on appetite control, cravings, metabolic health, energy, and quality of life in adults aged 18-65 years with a body mass index (BMI) between 25 and 30.
Participants will consume one capsule of resM™ GLP-1 Postbiotic and one scoop of resG prebeet ENERGY Prebiotic daily for 60 days. Data will be collected through daily check-ins, weekly surveys, and quality-of-life questionnaires administered through the Chloe mobile application.
The primary objective is to evaluate changes in appetite control and food cravings over 60 days of supplementation.
Read the detailed description
The GLP-1 Optimizer Bundle combines resM™ GLP-1 Postbiotic and resG prebeet ENERGY Prebiotic to support appetite control, cravings, metabolic health, energy, and lifestyle behaviors.
This is a prospective, open-label, single-arm consumer-use study conducted over 60 days in approximately 20 adults aged 18-65 years with BMI between 25 and 30.
Participants will consume:
one capsule of resM™ GLP-1 Postbiotic daily one scoop of resG prebeet ENERGY Prebiotic daily
Assessments will be collected electronically through the Chloe mobile application and include:
appetite and cravings surveys energy and mood assessments quality-of-life questionnaires lifestyle habit surveys consumer satisfaction assessments
The study aims to evaluate consumer-reported changes associated with daily supplementation and lifestyle guidance.
- Conditions
- Weight Loss, Metabolic Health, Quality of Life
- Being tested
- Combination Prebiotic and Postbiotic
- Keywords
- weight loss, quality of life, metabolic health, supplement, prebiotic, postbiotic, energy
- Medical subject headings
- Weight Loss
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Combination Prebiotic and PostbioticDietary supplement
Participants will take a combined dosage of prebiotic and postbiotic.
| Study group | Role | What they receive |
|---|---|---|
| Active Supplement Bundle | Experimental | resM™ GLP-1 Postbiotic, and resG prebeet ENERGY Prebiotic Receives: Dietary Supplement: Combination Prebiotic and Postbiotic |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Appetite Control and Food Cravings Survey Scores Over 60 Days
Participant-reported appetite control and food cravings will be assessed using daily and weekly questionnaires administered through the Chloe mobile application. Survey responses will evaluate changes in hunger, cravings, satiety, and eating behaviors over the study period.
Measured: Baseline through Day 60
Secondary outcomes (3)
Change in Energy and Mood Survey Scores Over 60 Days
Participant-reported energy levels and mood will be assessed using weekly questionnaires administered through the participant management application.
Measured: Baseline through Day 60
Change in Quality-of-Life Questionnaire Responses Over 60 Days
Quality-of-life assessments will evaluate participant-reported physical well-being, lifestyle habits, and overall satisfaction during the study period.
Measured: Baseline, Day 30, and Day 60
Participant Satisfaction and Willingness to Continue Product Use at Day 60
End-of-study surveys will assess participant satisfaction, perceived benefits, and willingness to continue using the supplement combination.
Measured: Day 60
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 May 2026
- Study start20 Oct 2025
- Primary completion5 May 2026
- Study completion5 May 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Weight LossStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 20 participants (actual)
Sponsor and investigators
- Lead sponsor
- Able Biolabs, LLC
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07608016
- Sponsor's protocol ID
- ABL-032502
- Acronym
- RESMRESG101
- Status last verified
- May 2026
- First submitted
- 29 Apr 2026
- Last updated
- 1 Jun 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Consumer Study to Evaluate the Efficacy of a Postbiotic and Prebiotic Supplement Combination in Supporting Weight Loss, Metabolic Health, and Quality of Life
- ClinicalTrials.gov ID
- NCT07608016
- Acronym / sponsor ID
- RESMRESG101 / ABL-032502
- Conditions
- Weight Loss, Metabolic Health, Quality of Life
- Keywords
- weight loss, quality of life, metabolic health, supplement, prebiotic, postbiotic, energy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- Able Biolabs, LLCUniversity, hospital or other
- Study start
- 20 Oct 2025 (actual)
- Primary completion
- 5 May 2026 (actual)
- Study completion
- 5 May 2026 (actual)
- First posted
- 27 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This consumer-use study evaluates the effects of a combined postbiotic and prebiotic supplement regimen on appetite control, cravings, metabolic health, energy, and quality of life in adults aged 18-65 years with a body mass index (BMI) between 25 and 30.
Participants will consume one capsule of resM™ GLP-1 Postbiotic and one scoop of resG prebeet ENERGY Prebiotic daily for 60 days. Data will be collected through daily check-ins, weekly surveys, and quality-of-life questionnaires administered through the Chloe mobile application.
The primary objective is to evaluate changes in appetite control and food cravings over 60 days of supplementation.
Detailed description
The GLP-1 Optimizer Bundle combines resM™ GLP-1 Postbiotic and resG prebeet ENERGY Prebiotic to support appetite control, cravings, metabolic health, energy, and lifestyle behaviors.
This is a prospective, open-label, single-arm consumer-use study conducted over 60 days in approximately 20 adults aged 18-65 years with BMI between 25 and 30.
Participants will consume:
one capsule of resM™ GLP-1 Postbiotic daily one scoop of resG prebeet ENERGY Prebiotic daily
Assessments will be collected electronically through the Chloe mobile application and include:
appetite and cravings surveys energy and mood assessments quality-of-life questionnaires lifestyle habit surveys consumer satisfaction assessments
The study aims to evaluate consumer-reported changes associated with daily supplementation and lifestyle guidance.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Active Supplement Bundle | Experimental | Dietary Supplement: Combination Prebiotic and PostbioticresM™ GLP-1 Postbiotic, and resG prebeet ENERGY Prebiotic |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Adults aged 18-65 years BMI between 25 and 30 Generally healthy Willing to comply with study procedures Access to smartphone or internet-enabled device for electronic questionnaires
- Exclusion Criteria Pregnant, planning pregnancy, or lactating History of bariatric surgery Prescription weight loss medication use within the past 90 days Current GLP-1 drug use History of substance abuse within the past 6 months Current use of supplements containing overlapping active ingredients Significant medical condition that may interfere with study participation or interpretation of results
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Combination Prebiotic and PostbioticParticipants will take a combined dosage of prebiotic and postbiotic. | Dietary supplement | Active Supplement Bundle |
Primary outcome
Change in Appetite Control and Food Cravings Survey Scores Over 60 Days
Time frame: Baseline through Day 60
Participant-reported appetite control and food cravings will be assessed using daily and weekly questionnaires administered through the Chloe mobile application. Survey responses will evaluate changes in hunger, cravings, satiety, and eating behaviors over the study period.
3 secondary outcomes
Change in Energy and Mood Survey Scores Over 60 Days
Time frame: Baseline through Day 60
Change in Quality-of-Life Questionnaire Responses Over 60 Days
Time frame: Baseline, Day 30, and Day 60
Participant Satisfaction and Willingness to Continue Product Use at Day 60
Time frame: Day 60
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Jun 2026.
- Individual participant dataSharing planned: No
Related trials for Weight Loss
RecruitingPhase 2
Oxytocin for Weight Loss in Adolescents
Obesity, Adolescent, Oxytocin
Active, not recruiting
Healthy Living After Knee Replacement
Arthroplasty, Overweight and Obesity
Active, not recruiting
Milk Fat Globule Membrane-Enhanced RUTF for Children With Severe Acute Malnutrition
Severe Acute Malnutrition, Cognitive Impairment
Recruiting
Preserving Muscle Mass During Incretin-Induced Weight Loss
Obesity (BMI > 35)
Not yet recruitingPhase 4
Comparing Different Medication Regimens to Maintaining Weight Loss Among Adults With Obesity Using GLP-1s
Obesity & Overweight, Cardiometabolic Health Indicators
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Combination Prebiotic and Postbiotic in people with Weight Loss and Metabolic Health, run by Able Biolabs, LLC at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Appetite Control and Food Cravings Survey Scores Over 60 Days (time frame: Baseline through Day 60). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jun 2026.